1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Akcea Therapeutics Inc (AKCA)

  7. Akcea Therapeutics Inc (AKCA) Financials

AKCA

Akcea Therapeutics Inc
18.17
0.00 (0.0%)
Upgrade to Real-Time

Akcea Therapeutics Inc. (AKCA) Fundamentals
Akcea Therapeutics Inc is a commercial-stage biopharmaceutical company focused on developing and commercializing drugs to treat patients with serious cardiometabolic diseases caused by lipid disorders. It is advancing a mature pipeline of novel drugs with the potential to treat multiple diseases. The company's drugs, volanesorsen, AKCEA-APO(a)-LRx, AKCEA-ANGPTL3-LRx and AKCEA-APOCIII-LRx, are all based on antisense technology developed by Ionis Pharmaceuticals, Inc.
SHARE INFORMATION
Market CapUS$ 1,846,353,471
Shares Outstanding101,615,491
Float100,175,399
Percent Float98.58%
Short Interest759,276.00
Short Percent Float0.7%
Short Interest Ratio0.68
Short Interest Date2020-09-30
Latest Fiscal Dividend Per ShareUS$ 0.00
Latest Fiscal RevenueUS$ 488,542,000
Latest Fiscal EPSUS$ 0.43
Latest Fiscal Date2019-12-31
DIVIDENDS
Dividend (3 Years)US$ 0.00
Dividend (5 Years)US$ 0.00
Ex Dividend Date-
Dividend RateUS$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions244
Institutional Holdings Date2020-09-30
Institutional Bought Previous 3 Months1,690,832
Institutional Holdings Percent46.7%
Institutional Sold Previous 3 Months5,877,682
Insider Holdings Date-
Insider Bought Previous 3 Months-
Insider Holdings Percent0.0
Insider Sold Previous 3 Months-
Insider Shares Owned1,440,092
TRADING INFO
52 Week HighUS$ 0.00
52 Week LowUS$ 0.00
52 Week High ChangeUS$ 0.00
21 Day Moving AverageUS$ 0.00
21 Day Extended Moving AverageUS$ 18.17
50 Day Moving AverageUS$ 0.00
50 Day Extended Moving AverageUS$ 18.17
200 Day Moving AverageUS$ 0.00
200 Day Extended Moving AverageUS$ 18.1069
10 Day Average Volume-
20 Day Average Volume-
30 Day Average Volume-
50 Day Average Volume-
Alpha0.015482
Beta1.4690
Standard Deviation0.240966
R20.104209
7 Day Price ChangeUS$ 0.00
7 Day Percent Change0.0%
21 Day Price ChangeUS$ 0.00
21 Day Percent Change0.0%
30 Day Price ChangeUS$ 0.00
30 Day Percent Change0.0%
Month to Date Price ChangeUS$ 0.00
Month to Date Percent Change0.0%
Quarter to Date Price ChangeUS$ 0.00
Quarter to Date Percent Change0.0%
180 Day Price ChangeUS$ 0.00
180 Day Percent Change0.0%
200 Day Price ChangeUS$ 0.00
200 Day Percent Change0.0%
Year to Date Price ChangeUS$ 0.00
Year to Date Percent Change0.0%

Akcea Therapeutics Inc. (AKCA) Key Ratios

PROFITABILITY
EBIT Margin-12.1%
EBITDA Margin-9.9%
Pre-Tax Profit Margin0.0%
Profit Margin Count-2.8%
Gross Margin94.9%
Profit Margin TOT-2.8%
INCOME STATEMENTS
RevenueUS$ 315,930,000
Revenue Per ShareUS$ 3.1091
Revenue (3 Years)US$ 105.45
Revenue (5 Years)US$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book4.60
Total Debt To Equity0.00
Int Coverage0.00
Current Ratio12.20
Leverage Ratio1.10
Quick Ratio11.50
Long Term Debt To Capital0.03
VALUATION MEASURES
PE Ratio0.00
Enterprise ValueUS$ 1,470,010,471
Price to Sales5.8442
Price to Free Cash14.20
PE High Last 5 Years0.00
Price To Book3.90
Price To Cash Flow18.90
PE Low Last 5 Years0.00
Price to Tangible Book4.60
MANAGEMENT EFFECTIVENESS
Receivables Turnover33.40
Invoice Turnover1.50
Assets Turnover0.70
Return Assets-8.68
Return on Equity-9.85
Return on Capital-9.48

Akcea Therapeutics Inc. (AKCA) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorErnst & Young LLP
CEODamien McDevitt
Emplyoees294
Last AuditUE
CIK0001662524
IndustryBiotechnology
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address22 Boston Wharf Road
9th Floor
Boston, MA 2110
Websitehttps://www.akceatx.com
Facsimile-
Telephone+1 617 207-0202
Emailalowe@akceatx.com
Your Recent History
NASDAQ
AKCA
Akcea Ther..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now
NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:au D:20230401 11:26:19